Author Information
James G. Krueger is affiliated with The Rockefeller University, New York, NY. He is a prominent researcher in the field of dermatology, particularly focusing on inflammatory skin diseases like psoriasis and hidradenitis suppurativa. His contributions to the understanding of these conditions have been substantial, involving both basic and clinical research.Research Contributions
James G. Krueger has made significant strides in the field of dermatology, with a particular focus on inflammatory skin diseases. In 2022 alone, he published several key papers on topics ranging from the efficacy of combination targeted therapies in hidradenitis suppurativa to the effects of Ustekinumab on serum protein levels associated with cardiovascular risk in psoriasis vulgaris. His research also delved into transcriptomic analysis of major orphan ichthyosis subtypes and the impact of IL-17RA blockade by brodalumab on inflammatory pathways. Earlier, in 2021, he contributed to studies on interleukin signaling in psoriasis, safety and efficacy of TYK2 inhibitors, and the effects of costimulatory blockade with Abatacept post-Ustekinumab withdrawal.Aliases
James G. Krueger is also known by various aliases in academic publications, including J Krueger, J. G. Krueger, J.g. Krueger, James G. Krueger, James G Krueger, Jim G Krueger, James Krueger, J G Krueger, and James Glenn Krueger.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
49,819 |
| h-index |
120 |
| Paper Count |
620 |
